All In MedTech

Device Trial Radar · NCT00811525

Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant

Last checked: Nov 20, 2026Latest source record: Dec 2, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Approved for marketing

Status

Approved for marketing

Enrollment

Not stated

Start

Aug 2004

Primary completion

Not stated

Sponsor

Lead sponsor
Mentor Worldwide, LLCNot on our public-company list
Sponsor type
Industry
First posted
Dec 19, 2008

More device trials from this sponsor

Design

Study type
Expanded access
Who can join
Female only, from 18 years

Summary

As written by the sponsor on the registry.

The Contour Profile Gel Continued Access Study is designed to demonstrate safety of Mentor's Mammary Prostheses in women who are undergoing primary augmentation, primary reconstruction, or revision. Safety information on the rate of capsular contracture, rupture, and infection will be collected, and used to help determine device safety. With approval of MemoryShape™ Medium Height, Moderate Profile (CPG 321) Breast Implants on June 14, 2013, CPG CA Study subject enrollment has closed and the study has converted to a post approval study for this style.

Conditions

  • Breast Augmentation
  • Breast Reconstruction
  • Breast Revision

Interventions

  • Mentor Siltex® Contour Profile Gel Mammary ProsthesisDevice

    The CPG mammary prosthesis is a silicone elastomer mammary device with a textured surface. The Siltex® (textured) shell consists of a smooth shell bonded to an additional layer of silicone that has a textured pattern imprinted into its surface. The Siltex® shell is textured to provide a disruptive surface for collagen interface. The CPG implant contains a gel that is a more cohesive silicone gel than that used in other Mentor gel implants. The gel is made from the same materials as Mentor's standard gel. The contour shape of the CPG is designed to provide inferior projection with reduced superior fullness. The CPG mammary prosthesis contains raised orientation marks on the anterior and posterior of the implant which may help the physician ensure proper placement. CPG was available in sizes 120 cc-775 cc and 5 styles with various projection and height options. With approval of MemoryShape™ (CPG 321) Breast Implants, the study converted to a post approval study for this style.

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.